tiprankstipranks
Editas Medicine Inc (EDIT)
NASDAQ:EDIT
Want to see EDIT full AI Analyst Report?

Compare Editas Medicine (EDIT) vs. Competitors

3,564 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Editas Medicine
$3.49
$335.82M
-3.11
89.07%
6 Buy
3 Hold
2 Sell
Moderate Buy
Cellectis SA
$4.42
$269.00M
-5.37
144.44%
2 Buy
0 Hold
0 Sell
Moderate Buy
Foghorn Therapeutics
$5.29
$250.71M
-3.95
-0.93%
6 Buy
0 Hold
0 Sell
Strong Buy
Elicio Therapeutics
$13.55
$202.50M
-5.18
52.53%
4 Buy
0 Hold
0 Sell
Strong Buy
Vor Biopharma
$16.59
$813.33M
>-0.01
283.65%
5 Buy
1 Hold
0 Sell
Strong Buy
Caribou Biosciences
$2.20
$229.11M
-1.70
103.45%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
EDIT
Editas Medicine
3.46
1.69
95.48%
CLLS
Cellectis SA
3.52
2.03
136.24%
FHTX
Foghorn Therapeutics
4.28
0.11
2.64%
ELTX
Elicio Therapeutics
11.44
3.69
47.61%
VOR
Vor Biopharma
14.97
10.28
219.19%
CRBU
Caribou Biosciences
2.36
1.39
143.30%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts